Eli Lilly and Comp. (LLY) stock Forecast for 2021 – 2025

Eli Lilly and Comp. (LLY) stock Forecast for 2022 – 2026

Last update: November 27, 2022 (08:38)

Sector: Healthcare

The share price of Eli Lilly and Company (LLY) now

What analysts predict: $379.47

52-week high/low: $368.82 / $229.57

50/200 Day Moving Average: $337.81 / $307.16

This figure corresponds to the average price over the previous 50/200 days. For Eli Lilly and Comp. stocks, the 50-day moving average is the support level today.

For Eli Lilly and Comp. stocks, the 200-day moving average is the support level today.

Are you interested in Eli Lilly and Company stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Eli Lilly and Comp. stock price in 2022, 2023, 2024, 2025, 2026. How much will one Eli Lilly and Comp. share be worth in 2022 - 2026?

When should I take profit in Eli Lilly and Comp. stock? When should I record a loss on Eli Lilly and Comp. stock? What are analysts' forecasts for Eli Lilly and Comp. stock? What is the future of Eli Lilly and Comp. stock? We forecast Eli Lilly and Comp. stock performance using neural networks based on historical data on Eli Lilly and Comp. stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Eli Lilly and Comp. stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Eli Lilly and Comp. shares. This happens once a day.




Historical and forecast chart of Eli Lilly and Comp. stock

The chart below shows the historical price of Eli Lilly and Comp. stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Eli Lilly and Comp. stock price can be found in the table below.

Long-term forecasts by years.

Eli Lilly and Comp. daily forecast for a month

Date Target Pes. Opt. Vol., %
Nov 29 371.63 365.61 376.98 3.11
Nov 30 376.09 369.32 381.73 3.36
Dec 01 366.61 361.77 373.32 3.19
Dec 02 368.04 365.72 375.11 2.57
Dec 03 363.62 359.04 367.77 2.43
Dec 04 373.99 370.06 377.91 2.12
Dec 05 378.70 371.43 385.63 3.82
Dec 06 383.81 380.70 387.73 1.85
Dec 07 384.27 378.62 391.65 3.44
Dec 08 376.43 369.66 385.13 4.19
Dec 09 367.06 359.24 375.10 4.41
Dec 10 367.17 364.53 369.48 1.36
Dec 11 370.58 363.36 375.25 3.27
Dec 12 369.14 361.61 374.12 3.46
Dec 13 378.11 373.23 385.03 3.16
Dec 14 385.48 376.23 389.30 3.47
Dec 15 392.88 389.11 395.59 1.67
Dec 16 388.29 385.37 394.93 2.48
Dec 17 384.33 375.91 389.05 3.50
Dec 18 379.25 375.04 383.80 2.34
Dec 19 383.12 379.33 385.42 1.61
Dec 20 373.35 368.98 375.82 1.85
Dec 21 379.06 372.47 387.93 4.15
Dec 22 390.09 385.30 393.49 2.13
Dec 23 397.00 389.38 404.86 3.98
Dec 24 391.16 385.88 399.73 3.59
Dec 25 396.09 392.41 404.29 3.03
Dec 26 389.79 383.36 394.12 2.81
Dec 27 381.02 375.99 386.97 2.92
Dec 28 384.57 380.87 390.22 2.45

Eli Lilly and Comp. Daily Price Targets


Eli Lilly and Comp. Stock Forecast 11-29-2022.

Forecast target price for 11-29-2022: $371.63.
Positive dynamics for Eli Lilly and Comp. shares will prevail with possible volatility of 3.017%.
Pessimistic target level: 365.61
Optimistic target level: 376.98

Eli Lilly and Comp. Stock Forecast 11-30-2022.

Forecast target price for 11-30-2022: $376.09.
Positive dynamics for Eli Lilly and Comp. shares will prevail with possible volatility of 3.251%.
Pessimistic target level: 369.32
Optimistic target level: 381.73

Eli Lilly and Comp. Stock Forecast 12-01-2022.

Forecast target price for 12-01-2022: $366.61.
Negative dynamics for Eli Lilly and Comp. shares will prevail with possible volatility of 3.094%.
Pessimistic target level: 361.77
Optimistic target level: 373.32

Eli Lilly and Comp. Stock Forecast 12-02-2022.

Forecast target price for 12-02-2022: $368.04.
Positive dynamics for Eli Lilly and Comp. shares will prevail with possible volatility of 2.502%.
Pessimistic target level: 365.72
Optimistic target level: 375.11

Eli Lilly and Comp. Stock Forecast 12-03-2022.

Forecast target price for 12-03-2022: $363.62.
Negative dynamics for Eli Lilly and Comp. shares will prevail with possible volatility of 2.373%.
Pessimistic target level: 359.04
Optimistic target level: 367.77

Eli Lilly and Comp. Stock Forecast 12-04-2022.

Forecast target price for 12-04-2022: $373.99.
Positive dynamics for Eli Lilly and Comp. shares will prevail with possible volatility of 2.078%.
Pessimistic target level: 370.06
Optimistic target level: 377.91

LLY (LLY) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Dec. 402.16 380.73 428.82 11.22

Eli Lilly and Comp. forecast for this year


Eli Lilly and Comp. Stock Prediction for Dec 2022

An uptrend is forecast for this month with an optimal target price of $402.16. Pessimistic: $380.73. Optimistic: $428.82



Eli Lilly and Comp. (LLY) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 436.67 392.96 450.29 12.73
Feb 422.47 410.94 463.67 11.37
Mar 393.92 364.21 409.79 11.12
Apr 415.94 400.80 456.49 12.20
May 431.08 387.36 456.29 15.11
Jun 438.36 404.17 470.27 14.06
Jul 446.91 405.66 480.61 15.59
Aug 452.14 433.33 487.99 11.20
Sep 411.58 387.50 451.71 14.21
Oct 377.87 351.35 399.98 12.16
Nov 337.59 316.53 360.41 12.18
Dec 377.09 361.40 406.50 11.09

Eli Lilly and Comp. (LLY) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 409.93 380.62 426.45 10.75
Feb 385.95 346.82 408.03 15.00
Mar 434.12 420.57 464.03 9.36
Apr 429.04 402.27 463.06 13.13
May 417.33 402.14 450.96 10.83
Jun 417.87 386.91 459.70 15.83
Jul 404.29 387.47 434.25 10.77
Aug 368.55 344.12 400.65 14.11
Sep 368.55 345.55 400.65 13.75
Oct 383.40 349.01 400.35 12.82
Nov 372.94 343.36 390.39 12.05
Dec 384.57 369.57 422.07 12.44

Eli Lilly and Comp. (LLY) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 380.57 349.90 417.18 16.13
Feb 399.87 380.11 439.37 13.49
Mar 351.52 320.45 382.14 16.14
Apr 350.61 324.63 373.40 13.06
May 305.03 293.13 324.46 9.66
Jun 276.08 264.96 302.64 12.45
Jul 307.67 296.87 336.46 11.77
Aug 325.26 301.16 345.14 12.74
Sep 360.36 334.59 370.20 9.62
Oct 384.72 356.21 394.72 9.76
Nov 382.22 362.84 403.59 10.10
Dec 386.20 373.14 423.85 11.96

Eli Lilly and Comp. (LLY) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 421.84 401.55 462.42 13.16
Feb 449.81 411.22 486.06 15.40
Mar 456.83 429.51 484.74 11.39
Apr 451.48 409.81 485.52 15.59
May 469.09 423.96 492.87 13.98
Jun 461.77 414.35 508.59 18.53
Jul 517.60 473.86 540.48 12.33
Aug 490.01 444.15 518.68 14.37
Sep 492.56 474.63 506.01 6.20
Oct 504.09 473.29 531.61 10.97
Nov 496.22 478.16 525.25 8.97
Dec 502.67 461.50 541.88 14.83

Eli Lilly and Comp. information and performance

Eli Lilly and Company is an American pharmaceutical company. It was founded in 1876 in Indianapolis, Indiana, where its headquarters are still located. It is known as the first company to start the industrial production of insulin (in 1923). The company operates in two areas: medicines for humans and veterinary medicines (a division of Elanco). The company’s products are sold in 120 countries.

www.lilly.com

Eli Lilly and Comp. Address

LILLY CORPORATE CTR, DROP CODE 1094, INDIANAPOLIS, IN, US

Market Capitalization: 343 175 800 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: 10 380 400 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: 46.31

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 2.183

Price/earnings to growth

DPS: 3.79

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: 0.0109

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 6.65

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 0.32
Quarterly Revenue Growth YOY: 0.025
Trailing PE: 54.27

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 39.06

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 12.19

Enterprise Value (EV) /Revenue

EV To EBITDA: 42.06

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 950178000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Eli Lilly and Comp. (LLY) stock dividend

Eli Lilly and Comp. last paid dividends on 11/14/2022. The next scheduled payment will be on 12/09/2022. The amount of dividends is $3.79 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.